A Phase II Placebo-controlled Intervention Trial of Oral N-acetylcysteine (NAC) for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Protection from UV-induced oxidative stress
Test whether NAC (N-acetylcysteine) can protect nevi from UV-induced oxidative stress
5 years
No
Douglas Grossman, MD, PhD
Principal Investigator
Huntsman Cancer Institute
United States: Institutional Review Board
HCI50308
NCT01612221
September 2012
October 2016
Name | Location |
---|---|
Huntsman Cancer Institute | Salt Lake City, Utah 84112 |